Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Instagram
  • Listen to CMAJ podcasts
Letters

Concerns with fibromyalgia guidelines

Mary-Ann Fitzcharles and Peter A. Ste-Marie
CMAJ September 17, 2013 185 (13) 1160-1161; DOI: https://doi.org/10.1503/cmaj.113-2133
Mary-Ann Fitzcharles
Associate professor of medicine, Division of Rheumatology (Fitzcharles), McGill University; the Alan Edwards Pain Management Unit (Fitzcharles, Ste-Marie), McGill University, Health Centre; the Faculty of Law (Ste-Marie), Université de Montréal, Montréal, Que.
MB ChB
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter A. Ste-Marie
Associate professor of medicine, Division of Rheumatology (Fitzcharles), McGill University; the Alan Edwards Pain Management Unit (Fitzcharles, Ste-Marie), McGill University, Health Centre; the Faculty of Law (Ste-Marie), Université de Montréal, Montréal, Que.
BA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

We thank Stein1 for her interest in our CMAJ article,2 which reflects concepts addressed by the 2012 Canadian fibromyalgia guidelines.3

We agree with Stein that major depression and fibromyalgia are distinct disorders, however there is considerable overlap. Evaluating patients with fibromyalgia for mood disorders, including depression, is imperative and not doing so could compromise optimal patient care. The effects of an antidepressant on pain have been shown to be independent of effects on mood for a single agent only.3 Nevertheless, the choice of an agent that may address more than 1 symptom should be considered beneficial. In the guidelines,3 recommendations pertaining to antidepressant use in fibromyalgia state that “all categories of antidepressant medications including TCAs, SSRIs and SNRIs may be used for treatment of pain and other symptoms in patients with fibromyalgia,” and that physicians should explain the pain-modulating effects of antidepressants to patients.3

With regard to exercise, we have difficulty accepting a report of disablement to be so severe as to preclude any form of health-related physical activity. Regular physical activity is recommended for all persons, irrespective of health status.3 The guidelines focus on the importance of a patient-tailored exercise approach for the management of fibromyalgia.

Because most patients are given the definitive diagnosis of fibromyalgia an average of 7 years after onset of symptoms, many become deconditioned and experience kinesiophobia. Introduction of health-related physical activity should be graduated and increased to reach optimum recommendations. Exercise may contribute to a good internal locus of control, whereby a patient considers he or she can positively influence their health status. Additionally, since the publication of the guidelines, studies of tai chi, qigong, and yoga speak to the benefits of exercise that incorporates a mind component.4

Finally, we agree that physicians must remain empathetic. However, subjective complaints can be used dishonestly, especially when disablement is claimed and the physician–patient trust may be abused. Gervais and colleagues have shown that 35% of patients with fibromyalgia who were on or seeking disability benefits failed a memory effort test compared with 4% of patients who were not on or seeking disability benefits.5 This contributes to skepticism regarding the disabling nature of fibromyalgia, and puts into question the high rate of disablement.

We emphasize that a diagnosis of fibromyalgia does not automatically equate with disablement. Each disability application must be evaluated according to merit, with attention to sound medical evidence. Because the optimal treatment goal for fibromyalgia is improved function, the health care community should encourage working-aged patients to reintegrate or remain in the workforce, rather than succumb to a passive disabled status.

References

  1. ↵
    1. Stein E
    . Concerns with fibromyalgia guidelines [letter]. CMAJ 2013;185:1160.
    OpenUrlFREE Full Text
  2. ↵
    1. Fitzcharles M-A,
    2. Ste-Marie PA,
    3. Pereira JX
    . Fibromyalgia: evolving concepts over the past 2 decades. CMAJ 2013;185:E645–51.
    OpenUrlFREE Full Text
  3. ↵
    1. Fitzcharles M,
    2. Ste-Marie PA,
    3. Goldenberg D,
    4. et al
    . Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome. Oshawa (ON): Canadian Pain Society; 2012:1–44.
  4. ↵
    1. Mist SD,
    2. Firestone KA,
    3. Jones KD
    . Complementary and alternative exercise for fibromyalgia: a meta-analysis. J Pain Res 2013;6:247–60.
    OpenUrlPubMed
  5. ↵
    1. Gervais RO,
    2. Russell AS,
    3. Green P,
    4. et al
    . Effort testing in patients with fibromyalgia and disability incentives. J Rheumatol 2001;28:1892–9.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 185 (13)
CMAJ
Vol. 185, Issue 13
17 Sep 2013
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Concerns with fibromyalgia guidelines
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Concerns with fibromyalgia guidelines
Mary-Ann Fitzcharles, Peter A. Ste-Marie
CMAJ Sep 2013, 185 (13) 1160-1161; DOI: 10.1503/cmaj.113-2133

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Concerns with fibromyalgia guidelines
Mary-Ann Fitzcharles, Peter A. Ste-Marie
CMAJ Sep 2013, 185 (13) 1160-1161; DOI: 10.1503/cmaj.113-2133
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • References
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • The 5 Ps need an update: toward a comprehensive sexual history
  • Don’t ignore perimenopause
  • Hospital-at-home programs in Canada: challenges and pitfalls
Show more Letters

Similar Articles

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected]

CMA Civility, Accessibility, Privacy

 

Powered by HighWire